FDA

Latest News

Tatiana Shepeleva-stock.adobe.com
FDA Approves First Generics of Xarelto

March 12th 2025

Two companies have received approved for a generic of the 2.5 mg tablet of anticoagulant rivaroxaban, which is used to reduce the risk of stroke and deep vein thrombosis.

wladimir1804 -stock.adobe.com
FDA Approves First Biosimilar of Xolair

March 10th 2025

FDA Approves Neffy 1 mg Nasal Spray for Pediatric Patients
FDA Approves Neffy 1 mg Nasal Spray for Pediatric Patients

March 6th 2025

FDA Approves Tevimbra for Advanced Esophageal Cancer at $15,828 Per Month
FDA Approves Tevimbra for Advanced Esophageal Cancer at $15,828 Per Month

March 5th 2025

© Iryna - stock.adobe.com
FDA Accepts Amneal’s BLA for Two Denosumab Biosimilars

March 4th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.